The Runx transcriptional co-activator, CBFβ, is essential for invasion of breast cancer cells
<p>Abstract</p> <p>Background</p> <p>The transcription factor Runx2 has an established role in cancers that metastasize to bone. In metastatic breast cancer cells Runx2 is overexpressed and contributes to the invasive capacity of the cells by regulating the expression o...
Main Authors: | Lopez-Camacho Cesar, Deng Wensheng, Mendoza-Villanueva Daniel, Shore Paul |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-06-01
|
Series: | Molecular Cancer |
Online Access: | http://www.molecular-cancer.com/content/9/1/171 |
Similar Items
-
Small Molecule Inhibitor of CBFβ-RUNX Binding for RUNX Transcription Factor Driven Cancers
by: Anuradha Illendula, et al.
Published: (2016-06-01) -
Extrinsic and intrinsic signals converge on the Runx1/CBFβ transcription factor for nonpeptidergic nociceptor maturation
by: Siyi Huang, et al.
Published: (2015-09-01) -
CBFβ is a facultative Runx partner in the sea urchin embryo
by: Rupp Dawn E, et al.
Published: (2006-02-01) -
Corrigendum to: “Small Molecule Inhibitor of CBFβ-RUNX Binding for RUNX Transcription Factor Driven Cancers” [EBioMedicine 8 (2016) 117–131]
by: Anuradha Illendula, et al.
Published: (2017-11-01) -
Molecular mechanisms of cooperative binding of transcription factors Runx1-CBFβ-Ets1 on the TCRα gene enhancer.
by: Kota Kasahara, et al.
Published: (2017-01-01)